Literature DB >> 26342561

Life-sustaining treatment orders, location of death and co-morbid conditions in decedents with Parkinson's disease.

Keiran K Tuck1, Dana M Zive2, Terri A Schmidt3, Julie Carter1, John Nutt1, Erik K Fromme4.   

Abstract

INTRODUCTION: End-of-life care in Parkinson's Disease (PD) is poorly described. Physician Orders for Life Sustaining Treatment (POLST) forms specify how much life-sustaining treatment to provide. This study aims to better understand end-of-life care in PD using data from the Oregon POLST and Death Registries.
METHODS: Oregon death certificates from the years 2010-2011 were analyzed. Death certificates were matched with forms in the Oregon POLST Registry. Descriptive analyses were performed for both the full PD dataset as well as those with POLST forms.
RESULTS: There were 1073 (1.8%) decedents with PD listed as a cause of death and 56,961 without. Three hundred and seventy three (35%) decedents with PD had a POLST form. POLST preferences were not significantly different between those with or without PD, however location of death was; hospital (13% PD vs 24% without p < 0.01), home (32% vs 40% p < 0.01) and care facility (52% vs 29% p < 0.01). Compared to those without a POLST or those without a Comfort Measures Only (CMO) order, decedents with PD and a CMO order were less likely to die in a hospital (5.4% vs 14.7% p < 0.01) and more likely to die at home (39.1% vs 29.1% p < 0.01). In those with PD, dementia was the most common comorbid condition listed on death certificates (16%).
CONCLUSION: Decedents with PD die less frequently at home than the general population. POLST forms mitigate some of this discrepancy. While not often thought to be terminal, PD and its complications are commonly recorded causes of death.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Advance care planning; Location of death; Parkinson's disease; Physician orders for life sustaining treatment (POLST)

Mesh:

Year:  2015        PMID: 26342561     DOI: 10.1016/j.parkreldis.2015.08.021

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  12 in total

Review 1.  Palliative Care for Parkinson's Spectrum Disorders: an Emerging Approach.

Authors:  Maya Katz
Journal:  Neurotherapeutics       Date:  2021-01-13       Impact factor: 7.620

Review 2.  Palliative Care for Movement Disorders.

Authors:  Christina L Vaughan; Benzi M Kluger
Journal:  Curr Treat Options Neurol       Date:  2018-02-21       Impact factor: 3.598

Review 3.  Palliative Care for Parkinson Disease.

Authors:  Hillary D Lum; Benzi M Kluger
Journal:  Clin Geriatr Med       Date:  2019-09-10       Impact factor: 3.076

4.  Age and Life-Sustaining Treatment Preferences in Parkinson Disease.

Authors:  Eric Jackowiak; Ashley Szpara; Vikas Kotagal
Journal:  Neurol Clin Pract       Date:  2021-06

5.  The influence of POLST on treatment intensity at the end of life: A systematic review.

Authors:  Kelly C Vranas; Wesley Plinke; Donald Bourne; Devan Kansagara; Robert Y Lee; Erin K Kross; Christopher G Slatore; Donald R Sullivan
Journal:  J Am Geriatr Soc       Date:  2021-09-22       Impact factor: 7.538

6.  Impact of the Physician Orders for Life-Sustaining Treatment (POLST) Program Maturity Status on the Nursing Home Resident's Place of Death.

Authors:  Aluem Tark; Mansi Agarwal; Andrew W Dick; Jiyoun Song; Patricia W Stone
Journal:  Am J Hosp Palliat Care       Date:  2020-09-03       Impact factor: 2.500

Review 7.  Prognostic predictors relevant to end-of-life palliative care in Parkinson's disease and related disorders: a systematic review.

Authors:  Umer Akbar; Robert Brett McQueen; Julienne Bemski; Julie Carter; Elizabeth R Goy; Jean Kutner; Miriam J Johnson; Janis M Miyasaki; Benzi Kluger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-03-31       Impact factor: 10.154

8.  Impaired Quality of Life and Need for Palliative Care in a German Cohort of Advanced Parkinson's Disease Patients.

Authors:  Martin Klietz; Amelie Tulke; Lars H Müschen; Lejla Paracka; Christoph Schrader; Dirk W Dressler; Florian Wegner
Journal:  Front Neurol       Date:  2018-03-06       Impact factor: 4.003

9.  Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation.

Authors:  Brian Lau; Niklaus Meier; Giulia Serra; Virginie Czernecki; Michael Schuepbach; Soledad Navarro; Philippe Cornu; David Grabli; Yves Agid; Marie Vidailhet; Carine Karachi; Marie-Laure Welter
Journal:  Neurology       Date:  2019-05-01       Impact factor: 9.910

10.  Advance Directives of German People with Parkinson's Disease Are Unspecific in regard to Typical Complications.

Authors:  Martin Klietz; Özlem Öcalan; Stephanie Stiel; Florian Wegner; Nils Schneider; Dirk Dressler
Journal:  Parkinsons Dis       Date:  2019-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.